Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
Jennifer YoungDevesh DahaleKathleen DemmelMaureen O'BrienJames I GellerJosh CourterDavid B HaslamLara Danziger-IsakovStuart L GoldsteinPublished in: Pediatric blood & cancer (2020)
Interventions to decrease AKI took a three-pronged approach. Collectively, this approach was proven successful with significant reductions in both rates of nephrotoxic medication exposure and associated AKI among hospitalized oncology patients.